Cite
HARVARD Citation
Grocholski, S. et al. (2018). Benefit of crizotinib in a lung cancer patient with discordant ALK testing results. Cancer treatment and research communications. pp. 13-16. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Grocholski, S. et al. (2018). Benefit of crizotinib in a lung cancer patient with discordant ALK testing results. Cancer treatment and research communications. pp. 13-16. [Online].